Baiheqingjin formula reduces inflammation in mice with asthma by inhibiting the PI3K/AKT/NF-κb signaling pathway.
Yan X, Tong X, Jia Y, Zhao Y, Zhang Q, Hu M, Li X, Li B, Ming X, Xie Y, Wu X, Yu X, Qu L, Xiong L, Huang F, Nie J.
Yan X, et al. Among authors: huang f.
J Ethnopharmacol. 2024 Mar 1;321:117565. doi: 10.1016/j.jep.2023.117565. Epub 2023 Dec 9.
J Ethnopharmacol. 2024.
PMID: 38081397